Sensus Healthcare, Inc. Available-for-sale Securities, Gross Unrealized Loss
Sensus Healthcare, Inc. (SRTS) reported Available-for-sale Securities, Gross Unrealized Loss of $4.81 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2020-05-11
- Sensus Healthcare, Inc. available-for-sale securities, gross unrealized loss for the quarter ending 2020-03-31 was $4.81K.
- Sensus Healthcare, Inc. available-for-sale securities, gross unrealized loss for fiscal 2018 was $623.00, a 5.95% increase from fiscal 2017.
- Sensus Healthcare, Inc. available-for-sale securities, gross unrealized loss for fiscal 2017 was $588.00.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 6 month | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|---|---|
| 2020-03-31 | $4.81K 10-Q · filed 2020-05-11 | ||
| 2019-06-30 | $530.00 10-Q · filed 2019-08-12 | ||
| 2018-12-31 | $623.00 10-K · filed 2020-03-06 | ||
| 2017-12-31 | $588.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |